NDC 70121-2701 – Oziltus

Denosumab 70 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC70121-2701

Product details

Brand name
Oziltus
Generic name
Denosumab-mobz
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761457
Marketed since
December 23, 2025
Listing expires
December 31, 2026
Pharmacologic class
RANK Ligand Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Oziltus →

Package NDC codes (1)

Package NDCDescriptionSince
70121-2701-11 VIAL in 1 CARTON (70121-2701-1) / 1.7 mL in 1 VIALDec 23, 2025